The US FDA has approved IntraBio for the treatment of a rare genetic disease
The U.S. Food and Drug Administration has approved a drug from IntraBio to treat a rare and deadly genetic disease, the health regulator said Tuesday, just days after the agency approved the first treatment for the condition.
BELIEBTE BEITRÄGE
IEA warns ‘electricity era’ will come after fossil fuels peak
Oktober 17, 2024
Easter Island fights global plastic waste vortex
Oktober 17, 2024
Egypt opens more galleries at its antiquities museum
Oktober 17, 2024
LIVEÜBERTRAGUNG